Addex Therapeutics Q1 EPS $(1.37) Up From $(5.20) YoY, Sales $268.83K Down From $542.43K YoY
Addex Therapeutics Q1 EPS $(1.37) Up From $(5.20) YoY, Sales $268.83K Down From $542.43K YoY
addex therapeutics 第一季度每股收益為$(1.37)，較去年同期$(5.20)上升，銷售額為$268.83K，較去年同期$542.43K下降。
Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.37) per share. This is a 73.69 percent increase over losses of $(5.20) per share from the same period last year. The company reported $268.83 thousand in sales this quarter. This is a 50.44 percent decrease over sales of $542.43 thousand the same period last year.
Addex Therapeutics (納斯達克: ADXN) 每股報告的季度虧損爲$(1.37)。這比去年同期每股虧損$(5.20)增長了73.69%。公司本季度銷售額爲268.83千美元。這比去年同期542.43千美元的銷售額下降了50.44%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。